United Health Products has partnered with NAMSA to sponsor a new clinical study of its CelluSTAT Hemostatic Gauze to help resolve an outstanding FDA warning letter. This collaboration provides UHP with exclusive data rights to support a revised PMA application, advancing the path toward regulatory approval.